HHS Sec. RFK Jr. Unveils NIH-CMS Joint Project to Tackle Autism and Chronic Diseases

In a bold move that underscores the Trump administration’s continued commitment to medical freedom, scientific transparency, and American innovation, Health and Human Services Secretary Robert F. Kennedy Jr. just unveiled a groundbreaking initiative that brings together two prominent Trump-aligned figures—Dr. Jay Bhattacharya of the National Institutes of Health (NIH) and Dr. Mehmet Oz of the Centers for Medicare and Medicaid Services (CMS). This partnership isn’t just about autism—it’s about revolutionizing the way America tackles chronic disease, restores integrity to public health, and puts patients first. Once again, President Donald J. Trump is proving that his America First agenda extends into every corner of government—including health care.

The new joint initiative, unveiled in a detailed HHS announcement, will initially focus on uncovering the long-ignored and highly controversial root causes of autism spectrum disorder (ASD). But unlike previous bureaucratic efforts mired in red tape and beholden to Big Pharma, this project is powered by open inquiry, secure access to real-world data, and leadership willing to challenge the failed health narratives of the past. The Biden-era health bureaucracies wanted to suppress these questions. Under Trump, we’re asking them.

Dr. Bhattacharya—known nationally for standing up to the COVID lockdown regime and exposing the dangers of public health overreach—expressed his excitement for this historic collaboration. He described the partnership as one that “could unlock landmark research into the complex factors that drive autism and chronic disease.” For years, families have been told to “trust the science” by agencies that refuse to ask tough questions. Now, with President Trump’s trusted experts in charge, science is finally returning to its original purpose: seeking truth, not serving special interests.

Dr. Mehmet Oz, CMS Administrator and a longtime Trump ally, echoed this vision. He emphasized the potential of the CMS-NIH collaboration to “drive innovation without sacrificing privacy,” signaling a major departure from the surveillance-style data practices of previous administrations. For families with children suffering from autism or other long-term conditions, this represents hope—hope that the days of vague answers and political censorship are over.

Secretary Kennedy made it clear that this project reflects a broader vision. Autism is just the beginning. The team plans to use this data-driven platform to investigate the rise of a wide array of chronic conditions that have exploded over the past two decades—including autoimmune diseases, neurological disorders, and vaccine injuries. That’s right—under President Trump’s leadership, nothing is off the table.

The announcement came on the same day that President Trump nominated Dr. Casey Means for Surgeon General, replacing the withdrawn nomination of Dr. Janette Nesheiwat. Dr. Means, a respected physician known for challenging establishment medical narratives, joins a growing team of reformers who are unafraid to disrupt the corrupted public health industry. It’s no coincidence that this nomination coincided with the autism initiative—the Trump administration is signaling a sweeping reset of our broken medical system.

Predictably, the corporate media tried to undermine the announcement. Outlets like the Associated Press framed the effort as a fishing expedition unlikely to yield results. They cited critics such as Helen Tager-Flusberg of the Coalition of Autism Scientists—one of many establishment figures who have built their careers on a narrow, pharmaceutical-approved definition of autism research. These same “experts” ignored environmental, immunological, and vaccine-related factors for years. Under Trump, those taboos are being dismantled.

HHS officials have made clear that this initiative is only the start of a much larger campaign to explore causes and cures for chronic illness. According to a 2024 study by Drexel University, there were over 846,000 autistic individuals enrolled in Medicaid as far back as 2016—a number that has likely risen dramatically. This massive data pool, when freed from bureaucratic censorship, could provide the first real breakthroughs in decades. That’s what President Trump promised the American people: real answers, real science, real reform.

This partnership is also a direct challenge to the pharmaceutical-industrial complex that has grown fat and unaccountable under past administrations. Trump made it clear during his first term that Big Pharma’s influence over Washington must be broken. From slashing drug prices to exposing vaccine mandates, Trump has consistently stood with the American people—not the corporate donors. This research effort follows that same principle.

Critics claim this project won’t succeed. But those critics are the same voices who said Operation Warp Speed was impossible, that border security was a fantasy, and that bringing back American manufacturing was a pipe dream. Time and again, Trump has proven them wrong. The NIH-CMS initiative is just the latest example of a White House focused on results—not political correctness.

More importantly, this research effort signals to the American people that the days of medical censorship are coming to an end. Secretary Kennedy, Dr. Bhattacharya, and Dr. Oz are not afraid to follow the science wherever it leads. And with President Trump backing their efforts, they have the freedom and support to uncover what the establishment doesn’t want us to know.

While the media downplays the announcement, millions of families are paying attention. They know that something is deeply broken in the modern healthcare system—and they’re ready for answers. Under Trump’s leadership, those answers are finally within reach.

This bold collaboration between NIH and CMS isn’t just about science—it’s about justice. It’s about restoring trust in our health institutions. It’s about honoring the families who were ignored, mocked, and dismissed for daring to ask questions. And it’s about delivering the health outcomes Americans deserve—not the ones handed down by elites in ivory towers.

Once again, President Donald J. Trump is leading where others refuse. This initiative is the first real step in decades toward breaking the grip of the medical establishment and reclaiming health freedom for the American people. With strong, independent minds at the helm, and a president who refuses to be silenced, the future of American healthcare is finally looking bright.